ArticleScientific reports2024
The subsequent risk of retinal vein occlusion disease after sinusitis diagnosis: a nationwide population-based study.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal vein occlusion (RVO) is a common retinal vascular disease that causes visual impairment. However, there is limited evidence regarding the relationship between sinusitis and risk of RVO. This study investigated the association between sinusitis and the subsequent risk of RVO disease. A retrospective cohort study was conducted and patients with sinusitis or RVO were selected from the National Health Insurance Research Database (NHIRD) of Taiwan. In this population-based study, we identified a total of 131,532 sinusitis patients, who were matched with 263,064 non-sinusitis individuals based on sex and age. The Cox proportional hazard regression was applied to demonstrate the adjusted hazard ratio (aHR) with 95% confidence interval (CI) of main outcomes. Our results showed that the crude hazard ratio (cHR) for the risk of RVO was 1.35 (95% CI: 1.20-1.52) in the sinusitis cohort compared with the non-sinusitis cohort. After adjustment for demographics and comorbidities in the multivariable cox regression, the adjusted hazard ratio (aHR) was 1.28 (95% CI: 1.13-1.44). Moreover, statistically significant differences were observed in the 14-year cumulative incidence of RVO (p < 0.0001), central RVO (p = 0.0002), and branch RVO (p = 0.0004) between the sinusitis and non-sinusitis cohorts. In conclusion, our study revealed that patients with sinusitis were at higher risk of being diagnosed with RVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.